1
TITLE: Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis  Full Text
AUTHORS: Laura Obici; John L Berk; Alejandra Gonzalez Duarte; Teresa Coelho; Julian Gillmore; Hartmut H J Schmidt; Matthias Schilling; Taro Yamashita; Celine Labeyrie; Thomas H Brannagan; Senda Ajroud Driss; Peter Gorevic; Arnt V Kristen; Jaclyn Franklin; Jihong H Chen; Marianne T Sweetser; Jing Jing Wang; David Adams;
PUBLISHED: 2020, SOURCE: AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, VOLUME: 27, ISSUE: 3
INDEXED IN: Scopus WOS
2
TITLE: Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
AUTHORS: Arnt V Kristen; Senda Ajroud Driss; Isabel Conceicao; Peter Gorevic; Theodoros Kyriakides; Laura Obici;
PUBLISHED: 2019, SOURCE: NEURODEGENERATIVE DISEASE MANAGEMENT, VOLUME: 9, ISSUE: 1
INDEXED IN: Scopus WOS
3
TITLE: Impact of Patisiran on Overall Health Status in hATTR Amyloidosis: Results from the APOLLO Trial
AUTHORS: Senda Ajroud Driss; David Adams; Teresa Coelho; Michael Polydefkis; Alejandra Gonzalez Duarte; Dianna Quan; Arnt Kristen; John L Berk; Angela M Partisano; Jared Gollob; Marianne T Sweetser; Jihong Chen; Sonalee Agarwal; Ole B Suhr;
PUBLISHED: 2019, SOURCE: 71st Annual Meeting of the American-Academy-of-Neurology (AAN) in NEUROLOGY, VOLUME: 92, ISSUE: 15
INDEXED IN: WOS
4
TITLE: Impact of Patisiran on overall health status in hATTR amyloidosis: Results from the APOLLO trial  Full Text
AUTHORS: Senda Ajroud Driss; David Adams; Teresa Coelho; Michael Polydefkis; Alejandra Gonzalez Duarte; Dianna Quan; Arnt Kristen; John Berk; Sonalee Agarwal; Angela Partisano; Jared Gollob; Marianne Sweester; Jihong H Chen; Ole Suhr;
PUBLISHED: 2018, SOURCE: Annual Meeting of the Peripheral-Nerve-Society in JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, VOLUME: 23, ISSUE: 4
INDEXED IN: WOS